Pure Global

Aliaxin SR Cross-Linked Hyaluronic Acid - FDA Registration CMDR-2025-03700

Access comprehensive regulatory information for Aliaxin SR Cross-Linked Hyaluronic Acid in the Philippines medical device market through Pure Global AI's free database. This device is registered under FDA registration number CMDR-2025-03700 and manufactured by Rose Pharma S.A. Via San Gottardo 10-6900 Lugano, Switzerland in Switserland. The device was registered on January 23, 2025.

This page provides complete registration details including manufacturer information, importer/distributor details (Metro Drug, Inc.), and regulatory compliance data from the official Philippines FDA medical device database. Pure Global AI offers free access to Philippines' complete medical device registry, helping global MedTech companies navigate FDA regulations efficiently.

Free Database
Powered by Pure Global AI
FDA Official Data
Switserland
CMDR-2025-03700
Aliaxin SR Cross-Linked Hyaluronic Acid
Registered medical device in Philippines
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Information
Product Name
Aliaxin SR Cross-Linked Hyaluronic Acid
Registration Number
CMDR-2025-03700
Manufacturer Details
Importer & Distribution
Importer/Distributor
Metro Drug, Inc.
Registration Dates
Issuance Date
January 23, 2025
Expiry Date
January 25, 2030